Clonal Evolution and Molecular Profiling of Recurrent Maxillary Ameloblastoma with Lung Metastasis Harboring SMO and PIK3CA Mutations

Authors: Yamaguchi, Yuji; Oka, Kumiko; Tamura, Yuka; Miyagi, Ryozo; Ohde, Yasuhisa; Mukaigawa, Takashi; Urakami, Kenichi; Sato, Fuyuki

Source journal: Head and neck pathology (2026-11-18)

DOI: 10.1007/s12105-026-01982-4

Abstract

PURPOSE: This study investigated genetic alterations in recurrent maxillary ameloblastoma with pulmonary metastases. METHODS: We analyzed tissue from a patient with a fifth recurrence of maxillary ameloblastoma and bilateral pulmonary metastases who underwent resection of the maxillary and lung lesions. Immunohistochemistry (IHC) for CK19, p53, and MIB1 was performed on the recurrent maxillary tumor and metastatic lung lesions. Genetic alterations were evaluated using a 225-gene cancer panel. RESULTS: Histologically, the recurrent maxillary tumor showed moderate atypia, whereas the metastatic lung tumor showed mild atypia. IHC demonstrated focal p53 positivity in the recurrent maxillary tumor and diffuse p53 positivity in the metastatic lung tumor. Genomic analysis identified identical SMO (L412F) and PIK3CA (E545K) mutations in the recurrent maxillary tumor and metastatic lung lesion. CONCLUSION: These findings support the involvement of Hedgehog and phosphoinositide 3-kinase (PI3K) signaling in the pathogenesis of metastatic maxillary ameloblastoma and demonstrate the potential value of genetic profiling for identifying therapeutic targets in aggressive or metastatic odontogenic tumors.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.